The Diabetic Investor
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Join host Larry Kaskel interview David Kliff, a diabetic himself and the publisher of the Diabetic Investor. Should you invest in the Diabetes Sector? What drug companies will pick up the Avandia business? Find out in this segment.
Overview
Join host Larry Kaskel interview David Kliff, a diabetic himself and the publisher of the Diabetic Investor. Should you invest in the Diabetes Sector? What drug companies will pick up the Avandia business? Find out in this segment.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?